Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Staphylococcus species aureus

Both microbial and host factors are important determinants in the development of osteomyelitis.2,3,9 Staphylococcus species possess bacterial adhesions, which promote their attachment to tissues and foreign devices. As such, S. aureus... [Pg.1178]

Shifts in the cutaneous microbiome have also been noted in chronic ulcer disease, such as those caused by venous stasis or diabetes (175). Patients with chronic ulcers treated with antibiotics have been shown to have an increased abundance of Pseudomonadaceae while an increase in Streptococcaceae has been noted in diabetic ulcers (175). A longitudinal shift in wound microbiota has also been shown to coincide with impaired healing in diabetic mice, and may interact with aberrantly expressed host cutaneous defense response genes leading to ulcerogenesis (176). When compared to controls, the feet of diabetic men has also been noted to have decreased populations of Staphylococcus species, a relative increase in the population of S. aureus and increased bacterial diversity, which may increase the risk for wound infections in diabetic patients (177). [Pg.98]

For many years S. aureus exotoxins have been considered the cause of associated conditions snch as blepharo-keratoconjunctivitis. It has been determined that all Staphylococcus species produce exotoxins, and becanse these species are foimd on the Uds of both normal and blepharitis patients, they are most likely not primarily responsible for the findings. More recent evidence suggests that an abnormal blink mechanism or destabilization of the tear film due to bacterial Upolytic enzyme pathways and increased hydrolysis of phosphoUpids may be the canse. It has also been shown that a delayed hypersensitivity to these toxins can prodnce the marginal keratitis seen in many patients. [Pg.383]

Davis JP, Chesney PJ, Wand PJ, LaVenture M (1980) Toxic-shock syndrome epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med 303 1429-1435 de Buyser ML, Morvan A, Giimont F, el Solh N (1989) Characterization of Staphylococcus species by libosomal RNA gene restriction patterns. J Gen Microbiol 135 989-999 de la Puente R, Suarez G, Schleifer KH (1985) Staphylococcus aureus subsp. anaerobius subsp. [Pg.167]

Hallin M, Deplano A, Denis O, De Mendonca R, De Ryck R, Struelens MJ (2007) Validation of pulsed-field gel electrophoresis and spa typing for long-term, nationwide epidemiological surveillance studies of Staphylococcus aureus infections. J CUn Microbiol 45 127-133 Hamels S, Gala JL, Dufour S, Vannuffel P, Zammatteo N, Remade J (2001) Consensus PCR and microarray for diagnosis of the genus Staphylococcus, species, and methiciUm resistance. Biotechniques 31 1364-1366, 1368, 1370-1362... [Pg.170]

Pathogens from the Staphylococcus genus are found in both the hospital and the community, and the most prevalent species, aureus,. causes illnesses that range from minor skin abscesses to severe pneumonia, meningitis, and infections of the heart, bloodstream, bone, and joint. Multiple strains of S. aureus are now antibiotic resistant, including a few strains that are partially resistant to vancomycin (18), the last effective antibiotic against... [Pg.221]

Coagulase-negative Staphylococcus species, particularly S. epidermidis, are the most common causes of catheter-related bacteremia [25], Heavy colonization of the skin-insertion site has been shown to be strongly correlated with catheter-related bacteremia. In hemodialysis patients, the risk of S. aureus bacteremia is six times greater than in nonhemodialysis patients. And numerous incidents of intravascular infection have been traced to microbially contaminated topical disinfectants. [Pg.149]

Enterotoxins. Toxic proteins formed by bacteria with molecular masses in the range from 27000 to 30000 which are usually excreted into the medium ( exotoxins). E. can be taken up with contaminated food or be formed by the bacteria colonizing the intestinal walls. Finally, the bacteria can penetrate the intestinal walls and then start to excrete the E. Some E. are thermally very stable and survive when food is boiled. E. from Salmonella and Staphylococcus species are the most frequent causes of food poisoning. Shortly after uptake, the symptoms of nausea, vomiting, diarrhea, and circulatory complaints occur. Deaths are rare and occur only when the subject is already in a weakened state. The sites of attack by E. vary, e.g., at intestinal epithelial cells or in the vegetative nervous system. For the production of antitoxins, E. are obtained by lysis of bacterial cells or from cell-free culture filtrates. E. have been detected, e. g., in the following bacterial species Bacillus cereus, Clostridium perfringens, Escherichia coli. Vibrio cholerae. Staphylococcus aureus, and Streptococcus faecalis. [Pg.209]

The mold isolated by Alexander Fleming in early 1940s was Penicillium notatum, who noted that this species killed his culture of Staphylococcus aureus. The production of penicillin is now done by a better penicillin-producing mould species, Penicillium chryso-genum. Development of submerged culture techniques enhanced the cultivation of the mould in large-scale operation by using a sterile air supply. [Pg.9]

Bacterial resistance to antibiotics has been recognized since the first drugs were introduced for clinical use. The sulphonamides were introduced in 1935 and approximately 10 years later 20% of clinical isolates of Neisseria gonorrhoeae had become resistant. Similar increases in sulphonamide resistance were found in streptococci, coliforms and other bacteria. Penicillin was first used in 1941, when less than 1 % of Staphylococcus aureus strains were resistant to its action. By 1947,3 8% of hospital strains had acquired resistance and currently over 90% of Staph, aureus isolates are resistant to penicillin. Increasing resistance to antibiotics is a consequence of selective pressure, but the actual incidence of resistance varies between different bacterial species. For example, ampicillin resistance inEscherichia coli, presumably under similar selective pressure as Staph, aureus with penicillin, has remained at a level of 30-40% for mai years with a slow rate of increase. Streptococcus pyogenes, another major pathogen, has remained susceptible to penicillin since its introduction, with no reports of resistance in the scientific literature. Equally, it is well recognized that certain bacteria are unaffected by specific antibiotics. In other words, these bacteria have always been antibiotic-resistant. [Pg.181]

Bone infarcts or sickling in the periosteum usually is indicated by pain and swelling over an extremity. Osteomyelitis also should be considered. Salmonella species are the most common cause of osteomyelitis in SCD children, followed by Staphylococcus aureus. 27 Select an appropriate antibiotic to cover the suspected organisms empirically. [Pg.1014]

Oral, narrow-spectrum antibiotic therapy with activity against Staphylococcus aureus and streptococcal species. Include coverage for MRSA (HA- or CA-MRSA) according to patient history and resistance patterns in the area. [Pg.1083]

The types of microorganisms found in various products are Pseudomonas species, including Pseudomonas aeruginosa, Salmonella, species, Staphylococcus aureus, and Escherichia coli. The USP and other pharmacopoeias recommend certain classes of products to be tested for specified microbial contaminants, e.g., natural plant, animal, and some mineral products for the absence of Salmonella species, suspensions for the absence of E. coli, and topically administered products for the absence of P. aeruginosa and S. aureus. Emulsions are especially susceptible to contamination by fungi and yeasts. Consumer use may also result in the introduction of microorganisms. For aqueous-based products, it is therefore mandatory to include a preservative in the formulation in order to provide further assurance that the product retains its pharmaceutically acceptable characteristics until it is used by the patient. [Pg.259]


See other pages where Staphylococcus species aureus is mentioned: [Pg.523]    [Pg.173]    [Pg.175]    [Pg.176]    [Pg.1098]    [Pg.54]    [Pg.85]    [Pg.164]    [Pg.198]    [Pg.481]    [Pg.512]    [Pg.683]    [Pg.773]    [Pg.17]    [Pg.58]    [Pg.166]    [Pg.114]    [Pg.250]    [Pg.257]    [Pg.246]    [Pg.328]    [Pg.373]    [Pg.431]    [Pg.109]    [Pg.145]    [Pg.189]    [Pg.248]    [Pg.200]    [Pg.445]    [Pg.214]    [Pg.147]    [Pg.150]    [Pg.500]    [Pg.189]    [Pg.350]    [Pg.244]   


SEARCH



5. aureus

Staphylococcus

Staphylococcus aureus

Staphylococcus species

© 2024 chempedia.info